Eco Diagnóstica, which had its self-test for Covid-19 approved by Anvisa (National Health Surveillance Agency) this Wednesday (23), plans to place the first shipment of the product in pharmaceutical retail soon after Carnival.
The initial forecast is to deliver 1 million units per week for the whole country, according to Vinicius Pereira, president of the company.
The exams are the same ones already sold by the manufacturer to laboratories and pharmacies, with the adapted packaging. According to the company, the self-tests should reach the final consumer at a price between R$ 49.90 and R$ 69.90, a value that is below the versions currently available, because the application service is not included.
This is the second self-test record approved by Anvisa. The first was that of the company CPMH Comércio e Indústria de Produtos Medicos Hospitales e Odontológicas, last Thursday (17).
So far, Anvisa has received at least 70 registration requests in the country.
The regulatory agency authorized the sale of self-tests in Brazil on January 28, but each supplier must apply for registration to market the product.
Joana Cunha with Andressa Motter and Ana Paula Branco
your subscription can be worth even more
Do you already know the advantages of being a Folha subscriber? In addition to having access to reports and columns, you have exclusive newsletters (find out here). You can also download our free app from the Apple Store or Google Play to receive alerts on the top news of the day. Your subscription helps us to make independent and quality journalism. Thank you!
your subscription is worth a lot
More than 180 reports and analyzes published each day. A team with more than 120 columnists. A professional journalism that supervises the public power, conveys useful and inspiring news, counterpoints the intolerance of social networks and draws a clear line between truth and lie. How much does it cost to help produce this content?
sign the sheet
I have over 8 years of experience in the news industry. I have worked for various news websites and have also written for a few news agencies. I mostly cover healthcare news, but I am also interested in other topics such as politics, business, and entertainment. In my free time, I enjoy writing fiction and spending time with my family and friends.
